Literature DB >> 17004285

Synthesis of the first chiral bidendate bis(trifluoromethyl)phosphane ligand through stabilization of the bis(trifluoromethyl)phosphanide anion in the presence of acetone.

Berthold Hoge1, Christoph Thösen, Ingo Pantenburg.   

Abstract

Lewis acid/Lewis base adduct formation of the P(CF3)2- ion and acetone leads to a reduced negative hyperconjugation and, therefore, limits the C--F bond activation. The resulting increased thermal stability of the P(CF3)2- ion in the presence of acetone allows selective substitutions and enables the synthesis of the first example of a chiral, bidentate bis(trifluoromethyl)phosphane ligand: a DIOP derivative, [(2,2-dimethyl-1,3-dioxolane-4,5-diyl)bis(methylene)]bis(diphenylphosphane), in which the phenyl groups at the phosphorus atoms are replaced by strong electron-withdrawing trifluoromethyl groups. The resulting high electron-acceptor strength of the synthesized bidentate (CF3)2P ligand is demonstrated by a structural and vibrational study of the corresponding tetracarbonyl-molybdenum complex. The stabilization of the P(CF3)2- ion in the presence of acetone is based on the formation of a dynamic Lewis acid/Lewis base couple, (CF3)2PC(CH3)2O-. Although there is no spectroscopic evidence for the formation of the formulated alcoholate ion, the intermediate formation of (CF3)2PC(CH3)2O- could be proved through the reaction with (CF3)2PP(CF3)2, which yields the novel phosphane-phosphinite ligand (CF3)2PC(CH3)2OP(CF3)2. This ligand readily forms square-planar Pt(II) complexes upon treatment with solid PtCl2.

Entities:  

Year:  2006        PMID: 17004285     DOI: 10.1002/chem.200600259

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Exploring the Reactivity of Unsymmetrical Diphosphanes toward Heterocumulenes: Access to Phosphanyl and Phosphoryl Derivatives of Amides, Imines, and Iminoamides.

Authors:  Natalia Szynkiewicz; Jarosław Chojnacki; Rafał Grubba
Journal:  Inorg Chem       Date:  2022-06-14       Impact factor: 5.436

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.